WEATHER UPDATE FEBRUARY 20. 2019

Rockville Office - Opening at 11am

Brandywine, Clinton, Lanham, Mt.Airy Offices Closed

Frederick Office Opening at 10am

 

 

 

USOR 17005

A Single-Arm, Open-Label, Multicenter Study of Enfortumab Vedotin (ASG - 22CE) for Treatment of Patients with Locally Advanced or Metastatic Urothelial Cancer who Previously Recieved Immune Checkpoint Inhibitor (CPI) Therapy

Disease Types

Urothelial Cancer

Available at

BethesdaBrandywineClintonColumbiaRockvilleSilver SpringWheaton

Contact

Linda Iovanni
MOHRSCH@usoncology.com